Skip to main content
. 2018 Nov 12;74(7):700–704. doi: 10.1136/thoraxjnl-2018-212547

Table 1.

Comparison of attendees and non-attendees of the second (T1) screening round

Variable T1 Screening round P values
Attendees Non- attendees
No of attendees (%) 1194 129
Mean age (years±SD) 64.7 (5.4) 64.2 (5.6) 0.34
Sex M/F (F%) 587/607 (50.8) 65/64 (49.6) 0.79
Median IMD rank (IQR) 2848 (3615) 2908 (4195) 0.79
BMI (±SD) 28.5 (5.4) 28.3 (5.7) 0.73
Lung cancer risk (PLCOM2012±SD) 4.8 (3.8) 5.4 (4.7) 0.13
Education (%) Less than ‘O’ level 822 (68.8) 93 (72.1) 0.58
‘O’ level 213 (17.8) 24 (18.6)
‘A’ level 44 (3.7) 3 (2.3)
University/college 77 (6.4) 5 (3.9)
University degree 26 (2.2) 4 (3.1)
Postgraduate/professional 12 (1.0) 0
Smoking status (%) Current 604 (50.6) 82 (63.6) 0.005
Former 590 (49.4) 47 (36.4)
Smoking exposure (mean±SD) Duration (years) 43.4 (8.3) 45.4 (7.0) 0.008
Cigarettes/day 24.1 (12.8) 23.9 (12.5) 0.83
Pack-years 51.2 (25.9) 53.4 (28.6) 0.37
Spirometry (mean±SD) FEV1 2.16 (0.7) 2.08 (0.7) 0.26
% predicted FEV1 84.9 (24.5) 81.0 (21.6) 0.09
FVC 3.17 (1.0) 3.10 (1.0) 0.44
% predicted FVC 100.4 (24.6) 96.3 (23.7) 0.07
FEV1:FVC ratio 67.9 (10.7) 67.6 (12.3) 0.75
Airflow obstruction Yes (%) 588 (49.6) 63 (53.1) 0.45
COPD/emphysema Yes (%) 386 (32.2) 37 (28.7) 0.40
FH lung cancer Yes (%) 326 (27.3) 32 (24.8) 0.54
MRC Dyspnoea Score (%) 1 781 (65.4) 72 (55.8) 0.13
2 261 (21.9) 32 (24.8)
3 98 (8.2) 14 (10.9)
4 53 (4.4) 11 (8.5)
5 1 (0.1) 0
Performance status (%) 0 655 (54.9) 60 (46.5) 0.12
1 403 (33.8) 46 (35.7)
2 116 (9.7) 19 (14.7)
3 20 (1.7) 4 (3.1)
4 0 0

BMI, Body Mass Index; FH, family history; IMD, Index of Multiple Deprivation; MRC, Medical Research Council.